Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications; during long term stability testing.
| Brand name | LANSOPRAZOLE |
| Generic name | LANSOPRAZOLE |
| Active ingredient(s) | LANSOPRAZOLE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 55111-399-90 |
| Full product label | Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90. |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 7,703 bottles |
| Recall initiated | 2022-03-23 |
| Report date | 2022-04-06 |
| Recall completed | 2024-02-02 |
| Recall number | D-0738-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗